
|Articles|November 5, 2015
Pediatric Drug Development & Therapeutics
Author(s)DIA
Advertisement
DIA’s Editor-in-Chief Stephen P. Spielberg, MD, PhD, FAAP, and Ronald Portman, MD, FAAP, discuss the Pediatric Drug Development & Therapeutics series of articles and how they can help inform the future of pediatric drug development on DIA’s podcast channel,
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Are Regulatory Factors Impacting Biosimilars
2
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
3
Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement
4
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
5




